Registration Filing
Logotype for Kopin Corporation

Kopin (KOPN) Registration Filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Kopin Corporation

Registration Filing summary

25 Nov, 2025

Company overview and business model

  • Specializes in innovative microdisplay technologies and optical systems for defense, enterprise, industrial, consumer, and medical sectors, with a focus on enhancing human performance in critical applications.

  • Product portfolio includes AMLCDs, LCOS, OLED, and MicroLED displays, as well as Application Specific Optical Solutions (ASOS) combining optics, electronics, and housings.

  • Supplies microdisplays and subsystems to the U.S. Department of Defense and international customers, with a global footprint in the Americas, Asia-Pacific, and Europe.

  • Recent strategic developments include a $15.4 million U.S. Army contract for MicroLED AR displays and a $15 million investment from Theon International Plc, supporting joint development and European expansion.

Financial performance and metrics

  • As of December 28, 2024, reported an accumulated deficit of $402.0 million and negative cash flow from operations for 2022–2024, with continued negative cash flow expected in 2025.

  • Cash and equivalents increased to $36.6 million at year-end 2024, primarily from $33.9 million in gross proceeds from a prior offering.

  • Accrued $24.8 million for litigation; substantial doubt exists about ability to continue as a going concern within one year of the annual report.

  • Net proceeds from the September 2025 PIPE offering were approximately $38.1 million after fees and expenses.

Use of proceeds and capital allocation

  • Will not receive proceeds from the resale of shares by selling stockholders; all registration expenses are borne by the company.

  • Proceeds from the recent PIPE were used to strengthen liquidity and support ongoing operations.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more